Top compounds associated with response to ITGAD


Feature Type Standardized
Nominal ANOVA
mRNA Pazopanib GDSC1000 pan-cancer AAC -0.03 0.4
mRNA NG-25 GDSC1000 pan-cancer AAC -0.026 0.4
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.027 0.4
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.029 0.4
mRNA paclitaxel gCSI pan-cancer AAC -0.046 0.4
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.03 0.4
mRNA triptolide CTRPv2 pan-cancer AAC -0.03 0.4
mRNA apicidin CTRPv2 pan-cancer AAC -0.027 0.4
mRNA GW843682X CTRPv2 pan-cancer AAC -0.03 0.4
mRNA MK-0752 CTRPv2 pan-cancer AAC 0.032 0.4
Download CSV